{"gene":"EIF2B2","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1993,"finding":"GSK-3 phosphorylates the epsilon subunit of eIF2B, and insulin rapidly inactivates GSK-3 (via phosphorylation of GSK-3), leading to reduced phosphorylation and activation of eIF2B; the effect is reversed by protein phosphatase-2A.","method":"Kinase assays on Mono-S fractions, immunoblotting with GSK-3α/β isoform-specific antibodies, phosphatase treatment, CHO cells expressing human insulin receptor","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — reciprocal biochemical evidence (kinase activity, immunoblot, PP2A reversal) with functional link; replicated in multiple subsequent studies","pmids":["8397507"],"is_preprint":false},{"year":1998,"finding":"GSK-3 phosphorylates Ser540 (Ser535 in some numbering) of the eIF2Bε subunit, and this phosphorylation inhibits eIF2B nucleotide exchange activity; insulin causes dephosphorylation of this site in a PI3K-dependent manner.","method":"Site-directed mutagenesis to identify phosphorylation site, in vitro kinase assay showing GSK-3 inhibits eIF2B activity, phosphorylation state measured in intact cells with PI3K inhibitors","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — in vitro assay with site identification (mutagenesis) and in-cell confirmation; replicated across multiple labs","pmids":["9468292"],"is_preprint":false},{"year":1996,"finding":"The GCN3 (α), GCD7 (β), and GCD2 (δ) subunits of yeast eIF2B form a stable regulatory subcomplex that mediates inhibition of eIF2B by phosphorylated eIF2α; this subcomplex lacks nucleotide exchange activity.","method":"Coimmunoprecipitation of overexpressed subunits, in vivo genetic suppressor analysis, eIF2B activity assays in subunit deletion strains","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus genetic epistasis plus enzymatic activity measurements; foundational study replicated by subsequent biochemistry","pmids":["8887689"],"is_preprint":false},{"year":1998,"finding":"Yeast eIF2B comprises two functional subcomplexes: a regulatory subcomplex (GCN3/GCD7/GCD2) that binds eIF2 with higher affinity for phosphorylated eIF2 but lacks exchange activity, and a catalytic subcomplex (GCD1/GCD6) that catalyzes GDP-GTP exchange and is not inhibited by phospho-eIF2.","method":"In vitro nucleotide-exchange assay with purified yeast eIF2B and eIF2; affinity-binding assay; characterization of regulatory mutations in GCN3 and GCD7","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro exchange assay with purified components, replicated and extended by subsequent structural studies","pmids":["9472020"],"is_preprint":false},{"year":2001,"finding":"Phosphorylated eIF2α (Ser51-P) binds tightly to the eIF2B regulatory subcomplex (containing GCD7/β and GCD2/δ subunits) in vitro, and this tight binding is required for inhibition of eIF2B guanine nucleotide exchange activity; mutations in eIF2α Ser51 or in GCD7 that block inhibition also abolish this interaction.","method":"GST pulldown of recombinant eIF2α (phosphorylated and unphosphorylated) with eIF2B regulatory subcomplex; genetic suppressor analysis; in vitro stimulation of binding by Ser51 phosphorylation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro binding assay with phospho-specific stimulation, corroborated by genetic epistasis; replicated in structural studies","pmids":["11438658"],"is_preprint":false},{"year":2000,"finding":"Phosphorylation of eIF2α Ser51 promotes complex formation between phospho-eIF2α and eIF2B, inhibiting eIF2B guanine nucleotide exchange activity; the Ser51Asp (phosphomimetic) mutant but not Ser51Ala mimics this inhibition.","method":"Baculovirus expression of wild-type, S51A, and S51D eIF2α mutants; in vitro GNE assay in reticulocyte lysate; interaction measured by co-precipitation","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis; consistent with multiple independent labs","pmids":["11041858"],"is_preprint":false},{"year":1998,"finding":"The α- and δ-subunits of mammalian eIF2B mediate sensitivity to inhibition by phosphorylated eIF2; eIF2B lacking the α-subunit is insensitive to eIF2(αP) and can exchange guanine nucleotides using eIF2(αP) as substrate; a double point mutation in the δ-subunit also confers insensitivity.","method":"Baculovirus co-expression of all five rat eIF2B subunits; purification of holoprotein and four-subunit complex; in vitro GNE assay with phosphorylated and unphosphorylated eIF2","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with purified recombinant complex and mutagenesis; first direct biochemical evidence for α/δ subunit roles","pmids":["9582312"],"is_preprint":false},{"year":1998,"finding":"eIF2 interacts with eIF2B specifically through the δ- and ε-subunits of eIF2B, and the binding site on eIF2β for eIF2B subunits maps to approximately 70 amino acids at the C-terminus; phosphorylation of eIF2α does not promote binding of eIF2B to isolated eIF2α but increases overall affinity of eIF2B for the eIF2 heterotrimer.","method":"Far-Western blot analysis mapping eIF2-eIF2B inter-subunit contacts; binding experiments with phosphorylated eIF2","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 — single lab far-Western method; consistent with but partially superseded by structural data","pmids":["9446619"],"is_preprint":false},{"year":2000,"finding":"The C-terminal region of the yeast eIF2Bε subunit (residues 518–712) constitutes the catalytic domain sufficient for nucleotide exchange activity and eIF2 binding; the N-terminal half of eIF2Bε is an activation domain that responds to complex formation with other eIF2B subunits to enhance exchange rate.","method":"N-terminal and C-terminal deletion analysis of yeast GCD6 (eIF2Bε) in vitro and in vivo; yeast complementation assays; GEF activity assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro and in vivo functional dissection with defined deletion series; replicated by Gomez et al. 2002","pmids":["10805739"],"is_preprint":false},{"year":2002,"finding":"The smallest catalytically active fragment of eIF2Bε (yeast Gcd6p residues 518–712) is sufficient for nucleotide exchange; deletion to residue 581 retains eIF2 binding but abolishes exchange, separating binding from catalytic function.","method":"In vitro GEF activity assays with N-terminal deletion series; eIF2-binding assays; in vivo complementation","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with defined deletion constructs and functional validation","pmids":["12356745"],"is_preprint":false},{"year":2001,"finding":"Mammalian eIF2B acts as a GDP dissociation stimulator (GDS) protein, releasing eIF2-bound GDP even without free nucleotide; the β-subunit of eIF2B, not the ε-subunit, interacts with GTP; the α-subunit is required for full exchange activity of the mammalian holoenzyme.","method":"In vitro GDP dissociation assay with purified mammalian eIF2B; GTP-binding assay of individual subunits; reconstitution of activity by adding recombinant eIF2Bα to α-deficient preparations","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified components; multiple assays including GTP-binding and GDP-release","pmids":["11323413"],"is_preprint":false},{"year":2005,"finding":"eIF2B and eIF2 co-localize to a specific large cytoplasmic body in yeast; eIF2 dynamically shuttles into these foci (FRAP analysis), while eIF2B is largely resident; three independent strategies to reduce eIF2B GEF activity all inhibit eIF2 shuttling, implicating this body as the site of guanine nucleotide exchange.","method":"Fluorescence microscopy co-localization; FRAP; genetic and pharmacological inhibition of eIF2B activity combined with localization readout","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — direct live-cell imaging (FRAP) tied to functional consequence; multiple orthogonal approaches in one study","pmids":["16157703"],"is_preprint":false},{"year":2007,"finding":"The eIF2B conserved residue E569 in the eIF2Bε catalytic domain is universally essential for GEF activity; W699 on a separate surface (~40 Å away) is critical for interaction with eIF2β; residues L568/E569 and W699 both contact eIF2γ, establishing that multiple surfaces of eIF2Bε mediate nucleotide exchange through contacts with both eIF2β and eIF2γ.","method":"Alanine-scanning mutagenesis of conserved surface residues; yeast complementation; in vitro GEF activity assay; binding assays with eIF2 subunits","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro assay plus mutagenesis plus in vivo validation; mechanistically precise","pmids":["17526738"],"is_preprint":false},{"year":2014,"finding":"eIF2B is a decamer (dimer of pentamers) rather than a pentamer, assembled through catalytic γ- and ε-subunits as a core with regulatory subunits arranged in asymmetric trimers; GTP binds to eIF2Bγ; cross-linking places eIF2 contacts at interfaces relevant to nucleotide exchange and its control.","method":"Native mass spectrometry, chemical cross-linking, surface accessibility measurements, homology modelling","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal MS-based structural methods; confirmed by subsequent cryo-EM studies","pmids":["24852487"],"is_preprint":false},{"year":2014,"finding":"Mammalian eIF2B is a decamer (dimer of eIF2BβγδεΑ pentamers), stabilized by two copies of eIF2Bα; eIF2Bδ plays a pivotal role in formation of the eIF2B(βγδε) tetramer; decameric eIF2B shows greater eIF2-binding activity than tetramers, explaining higher activity of the holoenzyme.","method":"Native mass spectrometry, co-immunoprecipitation of overexpressed complexes, eIF2-binding assays, analysis of eIF2B subunit levels across mouse tissues","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1–2 — native MS plus reciprocal Co-IP plus functional binding assays; consistent with Gordiyenko et al. 2014","pmids":["24532666"],"is_preprint":false},{"year":2013,"finding":"eIF2B has a GDI displacement factor (GDF) activity: the eIF2Bγ and eIF2Bε subunits displace eIF5 (which acts as a GDI for eIF2·GDP) from the eIF2·GDP/eIF5 complex prior to GEF action; GDF activity is insensitive to eIF2α phosphorylation (unlike GEF), and eIF2Bγ mutations impairing GCN4 control selectively impair GDF but not GEF function.","method":"Protein-protein interaction assays; nucleotide exchange kinetics; genetic analysis of eIF2Bγ mutations; separation of GDF and GEF activities","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — kinetic assays plus mutagenesis distinguishing GDF from GEF; novel functional dissection in one study with orthogonal methods","pmids":["24352424"],"is_preprint":false},{"year":2015,"finding":"ISRIB (a small molecule) activates eIF2B by stabilizing eIF2B dimers (decamers); ISRIB activity requires eIF2B (shown by shRNA screen); the eIF2B4 (δ-subunit) contributes to the ISRIB binding site; ISRIB renders cells insensitive to eIF2α phosphorylation by activating eIF2B.","method":"Reporter-based shRNA screen; biochemical stabilization of eIF2B dimers; structural analysis; cell-based ISR assay; development of analog series","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — functional genetic screen plus biochemical stabilization; replicated and extended by subsequent structural studies","pmids":["25875391"],"is_preprint":false},{"year":2018,"finding":"VWM disease mutations in eIF2B destabilize the decameric eIF2B holoenzyme; ISRIB rescues stability of VWMD mutant eIF2B by stabilizing the decameric form and restores residual catalytic activity to wild-type levels; ISRIB blocks ISR activation in VWMD patient cells.","method":"Biochemical stability assays of mutant eIF2B complexes; GEF activity assays; cell-based ISR reporter assays; SEC/MS analysis of complex assembly","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro biochemical assays plus mutagenesis plus cell-based functional assay; multiple orthogonal methods","pmids":["29489452"],"is_preprint":false},{"year":2019,"finding":"Cryo-EM structures of eIF2 bound to eIF2B reveal that the eIF2B heterodecamer is a static platform; one or two flexible eIF2 trimers bind and align with eIF2B's bipartite catalytic centers to catalyze nucleotide exchange; phosphorylation refolds eIF2α to contact eIF2B at a different interface, sequestering it in a nonproductive complex.","method":"Cryo-electron microscopy structural determination","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structure with mechanistic interpretation; confirmed by independent concurrent study (Kashiwagi et al. 2019)","pmids":["31048491"],"is_preprint":false},{"year":2019,"finding":"Cryo-EM and crystal structures of eIF2B in complex with unphosphorylated or phosphorylated eIF2 show that the two forms bind eIF2B in completely different modes: unphosphorylated eIF2 in a nucleotide exchange-active mode, phosphorylated eIF2 in an exchange-inactive mode that dominantly inhibits eIF2B.","method":"Cryo-electron microscopy and X-ray crystallography of eIF2B·eIF2 complexes","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — atomic-resolution structural determination with two distinct substrate states; independent replication of the Kenner et al. 2019 structures","pmids":["31048492"],"is_preprint":false},{"year":2020,"finding":"ISRIB antagonizes the ISR by allosteric mechanism: ISRIB-mediated acceleration of eIF2B nucleotide exchange is observed preferentially in the presence of phospho-eIF2; eIF2(αP) engagement of both eIF2B regulatory sites remodels the ISRIB-binding pocket and exchange-active pockets; eIF2(αP) and ISRIB reciprocally oppose each other's binding to eIF2B.","method":"Cryo-EM of eIF2B with eIF2(αP) and ISRIB; in vitro nucleotide exchange assay; eIF2B binding studies with ISR inhibitor and inhibitor-resistant mutants","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM plus in vitro reconstitution plus mutagenesis; mechanistically precise antagonistic allostery model","pmids":["33220178"],"is_preprint":false},{"year":2021,"finding":"eIF2B assembly state regulates ISR: in the absence of eIF2Bα, unassembled eIF2B tetramer subcomplexes accumulate and induce ISR; ISRIB drives assembly of inactive tetramers into active octamers/decamers; cryo-EM reveals eIF2(αP) converts eIF2B decamers into 'conjoined tetramers' with diminished substrate binding and catalytic activity via a conformational rocking motion.","method":"Cryo-EM; in vitro assembly/disassembly monitoring; in vivo ISRIB treatment; eIF2Bα knockout cell lines","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM plus in vivo genetic manipulation plus biochemical assembly assays; multiple orthogonal approaches","pmids":["33688831"],"is_preprint":false},{"year":2012,"finding":"TLR-TRIF signaling activates eIF2B GEF activity through PP2A-mediated serine dephosphorylation of the eIF2Bε subunit; PP2A is itself activated by decreased Src-family-kinase-induced tyrosine phosphorylation of its catalytic subunit; this pathway suppresses CHOP induction and translational repression in ER-stressed cells.","method":"PP2A activity assay; phosphorylation state analysis of eIF2Bε; siRNA knockdown of pathway components; in vivo mouse model of ER stress with TLR activation","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (kinase assays, phospho-state, KD, in vivo) in single high-impact study","pmids":["22231169"],"is_preprint":false},{"year":2017,"finding":"EIF2B2 mutations in VWMD patient cells hypersuppress translation during the ISR (ER stress), delaying stress-induced gene expression and interrupting GADD34-mediated negative feedback dephosphorylation of phospho-eIF2α, causing prolonged translational hyperrepression and failure to recover from stress.","method":"Translation rate measurements in patient fibroblasts; ISR reporter assays; GADD34 feedback analysis; small-molecule rescue (ISRIB and PERK inhibitor) in patient cells","journal":"RNA","confidence":"High","confidence_rationale":"Tier 2 — patient-derived cells, multiple assays, pharmacological rescue; mechanistically defines EIF2B2 mutation effect on ISR dynamics","pmids":["29632131"],"is_preprint":false},{"year":2021,"finding":"Sugar phosphates (e.g., glucose-6-phosphate) occupy an ancestral catalytic site in the eIF2Bα subunit, promote eIF2B holoenzyme formation, and enhance eIF2B GEF activity; a VWM disease mutation in the eIF2Bα ligand-binding pocket fails to engage sugar phosphates and is not stimulated by them.","method":"Unbiased ligand binding screens; enzymatic activity assays; structural studies of eIF2Bα with sugar phosphate ligands; analysis of VWM mutant","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — binding screens plus structural studies plus functional assay plus disease-relevant mutagenesis","pmids":["34103529"],"is_preprint":false},{"year":2021,"finding":"SFSV nonstructural protein NSs binds to the α-subunit of eIF2B in a manner competitive with phospho-eIF2α, allowing eIF2B to retain nucleotide exchange activity even in the presence of phospho-eIF2; cryo-EM of eIF2B·NSs·unphosphorylated eIF2 complex reveals the structural basis for ISR suppression.","method":"Cryo-EM structural determination; in vitro GEF activity assay in presence of NSs and eIF2(αP); ribosome profiling in NSs-expressing cells","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure plus in vitro functional assay plus genome-wide ribosome profiling","pmids":["34876589"],"is_preprint":false},{"year":2020,"finding":"Viral proteins (from a coronavirus and a picornavirus) independently acquired the ability to act as competitive inhibitors of phospho-eIF2–eIF2B interaction, allowing continued eIF2B-mediated GTP exchange and global translation despite high phospho-eIF2 levels.","method":"Cell-based ISR reporter assays; competition binding experiments; translation assays in virus-infected cells","journal":"Nature microbiology","confidence":"Medium","confidence_rationale":"Tier 2 — functional assay with mechanistic placement; single study","pmids":["32690955"],"is_preprint":false},{"year":1997,"finding":"Insulin activates eIF2B through a signaling pathway requiring PI3K; activation is blocked by dominant-negative PI3K and PI3K inhibitors but not rapamycin or a Sos mutant; eIF2B and GSK-3 are regulated reciprocally, and dominant-negative PI3K abolishes insulin-induced GSK-3 inhibition, placing PI3K upstream of GSK-3 in the eIF2B activation pathway.","method":"PI3K inhibitors (wortmannin), dominant-negative PI3K/Sos mutants, GSK-3 and eIF2B activity assays, rapamycin treatment","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with dominant-negative constructs and pharmacological inhibitors; replicated across multiple studies","pmids":["9237674"],"is_preprint":false},{"year":2001,"finding":"In S. cerevisiae, a proline-to-serine allelic variant at position 180 of the GCD1 (eIF2Bγ) subunit confers translational regulation in response to fusel alcohols; fusel alcohols target eIF2B to inhibit translation initiation.","method":"Genetic mapping; strain-specific phenotypic analysis; translation assays in eIF2B subunit mutants","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 — genetic mapping to specific eIF2Bγ residue with functional translation assay; single lab","pmids":["11707417"],"is_preprint":false},{"year":2020,"finding":"Under starvation-induced cytosolic acidification, yeast eIF2B forms enzymatically inactive filaments that promote rapid and efficient downregulation of translation; filamentation is independent of the Gcn2 kinase pathway and site-specific variants suggest assembly leads to inactive filaments supporting stress survival and fast recovery.","method":"Fluorescence microscopy of eIF2B filaments; pH measurements; site-directed mutagenesis; translation assays in filament-incompetent mutants; stress survival assays","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 — direct imaging plus functional mutagenesis; novel mechanism but single lab, yeast model","pmids":["32554487"],"is_preprint":false},{"year":2015,"finding":"Crystal structure of the eIF2B regulatory subcomplex (RSC) reveals it exists as a hexamer composed of two eIF2Bβδ heterodimers and one eIF2Bα2 homodimer; eIF2Bα specifically binds AMP and GMP as ligands in a pocket homologous to sugar-metabolizing enzymes; structural and mutational data define how RSC interacts with eIF2 and mediates inhibition.","method":"X-ray crystallography of eIF2Bβ, eIF2Bδ, and eIF2B(βδ)2 from Chaetomium thermophilum; solution biochemistry showing hexameric assembly; mutational analysis; ligand binding assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — crystal structures of multiple RSC components plus biochemical and mutational validation","pmids":["26384431"],"is_preprint":false},{"year":2016,"finding":"Crystal structure of Schizosaccharomyces pombe eIF2B decamer reveals the structural mechanism by which phosphorylation of eIF2α Ser51 inhibits eIF2B GEF activity; structure-based in vitro analyses confirm mechanism.","method":"X-ray crystallography of full eIF2B decamer; structure-based in vitro GEF activity analyses","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 — first crystal structure of full eIF2B decamer with structure-based functional validation","pmids":["27627185"],"is_preprint":false},{"year":2017,"finding":"eIF2α phosphorylation destabilizes an autoregulatory intramolecular interaction within eIF2α (novel inhibition mechanism); NMR and fluorescence spectroscopy provide the first structural model of the eIF2B·eIF2-GDP complex and intermediates including apo-eIF2 and eIF2-GTP, directly informing the catalytic mechanism.","method":"NMR spectroscopy; fluorescence spectroscopy; site-directed mutagenesis; thermodynamic analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — NMR plus fluorescence plus mutagenesis plus thermodynamics; multiple orthogonal methods in one study","pmids":["29036434"],"is_preprint":false},{"year":2019,"finding":"RGS2, via its eIF2B-interacting domain, interacts with eIF2B and inhibits global protein synthesis; this interaction selectively promotes translational upregulation of ATF4 and CHOP in a manner independent of eIF2α phosphorylation.","method":"Expression of full-length RGS2 and its eIF2B-binding domain fragment; translation rate assays; ATF4/CHOP protein level measurements; cell-based ISR assays","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, overexpression approach with functional protein-level readout; mechanistic placement proposed but not fully reconstituted","pmids":["30826455"],"is_preprint":false}],"current_model":"eIF2B is a heterodecameric (dimer of pentamers, subunits α–ε × 2) guanine nucleotide exchange factor (GEF) and GDI displacement factor (GDF) for eIF2, where the catalytic γ/ε subcomplex catalyzes GDP→GTP exchange via direct contacts with both eIF2β and eIF2γ, the regulatory α/β/δ subcomplex binds phospho-eIF2α with high affinity to competitively inhibit exchange (integrated stress response), GSK-3 phosphorylates eIF2Bε at Ser535/540 to inhibit activity while insulin/PI3K signaling inactivates GSK-3 to dephosphorylate and activate eIF2B, ISRIB activates eIF2B by allosterically stabilizing the decameric assembly and antagonizing the conformational changes induced by phospho-eIF2α, and EIF2B2 (β-subunit) mutations cause Vanishing White Matter disease by destabilizing the decamer and hypersuppressing translation during stress."},"narrative":{"teleology":[{"year":1993,"claim":"Establishing that eIF2B is regulated by insulin-responsive phosphorylation resolved how growth-factor signaling controls translation initiation: GSK-3 directly phosphorylates the eIF2Bε subunit to inhibit GEF activity, and insulin reverses this via GSK-3 inactivation.","evidence":"Kinase assays on Mono-S fractions, GSK-3 isoform-specific immunoblots, PP2A reversal in CHO cells expressing human insulin receptor","pmids":["8397507"],"confidence":"High","gaps":["Exact phosphorylation site on eIF2Bε not yet mapped","Pathway between insulin receptor and GSK-3 undefined"]},{"year":1997,"claim":"Defining PI3K as the intermediate between insulin signaling and GSK-3/eIF2B placed eIF2B activation within the canonical PI3K-Akt pathway, establishing eIF2B as a downstream translational effector of growth factor signaling.","evidence":"Dominant-negative PI3K, wortmannin, rapamycin insensitivity; GSK-3 and eIF2B activity assays","pmids":["9237674"],"confidence":"High","gaps":["Whether Akt directly phosphorylates GSK-3 to control eIF2B not formally shown here","Tissue-specific regulation not addressed"]},{"year":1998,"claim":"Identifying the eIF2B regulatory (α/β/δ) and catalytic (γ/ε) subcomplexes, and showing that the regulatory subcomplex mediates phospho-eIF2α sensitivity while lacking exchange activity, defined the bipartite architecture of eIF2B and the mechanistic basis for ISR transduction.","evidence":"Purified yeast and mammalian subcomplexes; in vitro GEF assays with phospho- and unphospho-eIF2; baculovirus reconstitution; mutagenesis of α and δ subunits","pmids":["9472020","9582312","8887689"],"confidence":"High","gaps":["Stoichiometry of the holoenzyme unknown","How phospho-eIF2α binding to regulatory subcomplex inhibits catalytic subcomplex activity unclear"]},{"year":1998,"claim":"Mapping the GSK-3 phosphorylation site to Ser540 (Ser535) on eIF2Bε and demonstrating that this single phosphorylation inhibits GEF activity provided the molecular target for PI3K-dependent translational control.","evidence":"Site-directed mutagenesis, in vitro kinase assay, phosphorylation-state analysis in intact cells with PI3K inhibitors","pmids":["9468292"],"confidence":"High","gaps":["Whether additional sites contribute to regulation not excluded","Structural basis of inhibition by Ser540 phosphorylation unknown"]},{"year":2000,"claim":"Demonstrating that a C-terminal fragment of eIF2Bε (residues 518–712) is the minimal catalytic domain sufficient for nucleotide exchange separated catalytic and regulatory functions within a single subunit and showed that complex formation with other subunits enhances activity.","evidence":"Deletion analysis of yeast GCD6 in vitro and in vivo; complementation assays; GEF activity assays","pmids":["10805739","12356745"],"confidence":"High","gaps":["How N-terminal activation domain of eIF2Bε communicates with catalytic domain structurally undefined","Minimal domain lacks ISR regulation"]},{"year":2001,"claim":"Showing that phospho-eIF2α binds tightly and specifically to the regulatory subcomplex while mutations abolishing this binding also abolish GEF inhibition established competitive substrate sequestration as the inhibition mechanism.","evidence":"GST pulldown with phospho- and unphospho-eIF2α; genetic suppressor analysis in yeast","pmids":["11438658","11041858"],"confidence":"High","gaps":["Structural details of the phospho-eIF2α–regulatory subcomplex interface unknown","Whether sequestration is the sole mechanism or allosteric effects contribute unclear"]},{"year":2005,"claim":"Discovering that eIF2B and eIF2 co-localize to a specific cytoplasmic body in yeast where eIF2 dynamically shuttles for nucleotide exchange revealed that GEF activity is spatially organized.","evidence":"Fluorescence microscopy co-localization, FRAP, genetic and pharmacological perturbation of eIF2B activity in yeast","pmids":["16157703"],"confidence":"High","gaps":["Whether mammalian eIF2B forms equivalent bodies not shown","Molecular determinants of body formation unknown"]},{"year":2007,"claim":"Alanine-scanning mutagenesis of eIF2Bε showed that the catalytic domain contacts both eIF2β and eIF2γ through spatially separated surfaces (~40 Å apart), establishing that nucleotide exchange requires multipoint engagement of the substrate.","evidence":"Conserved-residue mutagenesis, yeast complementation, in vitro GEF and binding assays","pmids":["17526738"],"confidence":"High","gaps":["Atomic structure of the eIF2B–eIF2 interface not yet available","Whether the two contact surfaces function sequentially or simultaneously unknown"]},{"year":2012,"claim":"Demonstrating that TLR-TRIF signaling activates eIF2B through PP2A-mediated dephosphorylation of eIF2Bε revealed an immune-cell-specific input to translational control during ER stress.","evidence":"PP2A activity assay, phospho-state analysis of eIF2Bε, siRNA knockdown, in vivo mouse ER stress model with TLR activation","pmids":["22231169"],"confidence":"High","gaps":["Which Src-family kinase member mediates PP2A phosphorylation in this context not identified","Generalizability beyond macrophage/innate immunity not tested"]},{"year":2013,"claim":"Identifying eIF2B's GDI displacement factor (GDF) activity — mechanistically separable from GEF activity — showed that eIF2Bγ/ε first displace eIF5 (the GDI) from eIF2·GDP before catalyzing exchange, and that ISR phospho-eIF2α selectively inhibits GEF but not GDF.","evidence":"Protein interaction and kinetic assays distinguishing GDF from GEF; eIF2Bγ mutations selectively impairing GDF","pmids":["24352424"],"confidence":"High","gaps":["Structural basis of GDF activity unknown","Whether GDF is rate-limiting in vivo not established"]},{"year":2014,"claim":"Native mass spectrometry established that eIF2B is a heterodecamer (dimer of pentamers) rather than a pentamer, with eIF2Bα stabilizing the dimer and eIF2Bδ pivotal for tetramer formation, explaining why the holoenzyme has greater substrate-binding and catalytic activity than subcomplexes.","evidence":"Native MS, chemical cross-linking, co-IP, eIF2-binding assays, tissue-level subunit stoichiometry","pmids":["24852487","24532666"],"confidence":"High","gaps":["High-resolution structure not yet available","How dimerization enhances catalysis mechanistically unclear"]},{"year":2015,"claim":"The discovery that ISRIB activates eIF2B by stabilizing its decameric assembly and rendering cells insensitive to eIF2α phosphorylation provided both a pharmacological tool and a therapeutic lead for ISR-related diseases.","evidence":"shRNA screen identifying eIF2B as ISRIB target; biochemical stabilization of eIF2B dimers; eIF2B4 (δ) as binding site component; cell-based ISR assay","pmids":["25875391"],"confidence":"High","gaps":["Atomic details of ISRIB binding site on eIF2B not resolved","In vivo pharmacokinetics and CNS penetrance not addressed"]},{"year":2015,"claim":"Crystal structures of the eIF2B regulatory subcomplex revealed the hexameric (α₂β₂δ₂) architecture and showed that eIF2Bα binds nucleotide ligands (AMP/GMP) in an ancestral sugar-phosphatase pocket, linking metabolic sensing to translational control.","evidence":"X-ray crystallography of eIF2Bβ, δ, and (βδ)₂ from Chaetomium thermophilum; ligand binding assays; mutational analysis","pmids":["26384431"],"confidence":"High","gaps":["Physiological significance of nucleotide binding to eIF2Bα unclear","Whether AMP/GMP binding modulates ISR sensitivity untested"]},{"year":2016,"claim":"The first crystal structure of a full eIF2B decamer (S. pombe) provided the structural framework for understanding how phospho-eIF2α Ser51 inhibits GEF activity at the holoenzyme level.","evidence":"X-ray crystallography of full decamer; structure-based in vitro GEF analyses","pmids":["27627185"],"confidence":"High","gaps":["Structure of eIF2B bound to eIF2 substrate not available","Mammalian eIF2B structure not yet determined"]},{"year":2017,"claim":"Demonstrating that EIF2B2 mutations in VWM patient cells cause hypersuppression of translation during ER stress — by disrupting GADD34-mediated feedback dephosphorylation of phospho-eIF2α — defined the pathogenic mechanism of Vanishing White Matter disease at the translational level.","evidence":"Translation rate measurements in patient fibroblasts; ISR reporters; GADD34 feedback analysis; pharmacological rescue with ISRIB and PERK inhibitor","pmids":["29632131"],"confidence":"High","gaps":["Why white matter is selectively vulnerable not explained","Whether all VWM-causing EIF2B2 alleles act through the same mechanism not tested"]},{"year":2018,"claim":"Showing that VWM disease mutations destabilize the eIF2B decamer and that ISRIB rescues both stability and catalytic activity connected the biophysical defect (decamer instability) to pathology and validated a therapeutic strategy.","evidence":"Biochemical stability assays, GEF activity assays, SEC/MS of mutant complexes, cell-based ISR rescue in VWMD patient cells","pmids":["29489452"],"confidence":"High","gaps":["In vivo efficacy of ISRIB in VWM animal models not shown","Not all VWM mutations tested"]},{"year":2019,"claim":"Cryo-EM structures of eIF2B bound to unphosphorylated and phosphorylated eIF2 revealed two completely distinct binding modes — productive (exchange-competent) versus nonproductive (inhibitory) — providing the atomic-level mechanism for ISR-mediated translational control.","evidence":"Cryo-EM and X-ray crystallography of eIF2B·eIF2 complexes in both phosphorylation states, from two independent groups","pmids":["31048491","31048492"],"confidence":"High","gaps":["Transition dynamics between productive and nonproductive modes not captured","Role of individual regulatory subunits including β in the conformational switch not fully dissected"]},{"year":2020,"claim":"Structural and biochemical demonstration that ISRIB and phospho-eIF2α reciprocally oppose each other's binding to eIF2B through allosteric remodeling of shared pockets established ISRIB's mechanism as direct antagonism of the ISR conformational switch.","evidence":"Cryo-EM of eIF2B with eIF2(αP) and ISRIB; in vitro nucleotide exchange assay; ISRIB-resistant mutants","pmids":["33220178"],"confidence":"High","gaps":["Whether ISRIB efficacy varies across eIF2B mutant backgrounds (e.g., different VWM alleles) not systematically explored"]},{"year":2020,"claim":"Discovery that viral proteins from diverse virus families independently evolved to competitively block phospho-eIF2 binding to eIF2B demonstrated that the regulatory subcomplex interface is a convergent target for immune evasion.","evidence":"Cell-based ISR reporter assays; competition binding experiments; translation assays in virus-infected cells","pmids":["32690955"],"confidence":"Medium","gaps":["Direct structural visualization of viral protein–eIF2B interaction not shown in this study","Breadth across additional virus families not tested"]},{"year":2021,"claim":"Demonstrating that eIF2(αP) converts active eIF2B decamers into 'conjoined tetramers' with diminished catalysis via a rocking motion, and that ISRIB rescues assembly even without eIF2Bα, unified the assembly-state and allosteric models of ISR regulation.","evidence":"Cryo-EM; in vitro assembly monitoring; ISRIB treatment; eIF2Bα knockout cells","pmids":["33688831"],"confidence":"High","gaps":["Whether conjoined tetramers form in vivo under physiological stress not directly demonstrated","Contribution of eIF2Bβ to the rocking conformational change not isolated"]},{"year":2021,"claim":"Identification of sugar phosphates (e.g., glucose-6-phosphate) as natural ligands that occupy an ancestral catalytic site in eIF2Bα, promote decamer formation, and enhance GEF activity linked cellular metabolic state to eIF2B regulation independently of phospho-eIF2α.","evidence":"Unbiased ligand-binding screens; enzymatic activity assays; structural studies; VWM mutant analysis","pmids":["34103529"],"confidence":"High","gaps":["Physiological range of sugar-phosphate concentrations needed to modulate eIF2B in vivo not established","Whether eIF2Bβ pocket also binds metabolites not tested"]},{"year":null,"claim":"The specific contribution of the eIF2Bβ subunit to decamer assembly, ISR sensing, and GEF catalysis — as opposed to the roles of the structurally related α and δ subunits — remains incompletely resolved at the atomic level.","evidence":"","pmids":[],"confidence":"Low","gaps":["No subunit-specific deletion or point-mutation series for EIF2B2 dissecting its unique versus redundant roles within the regulatory subcomplex","Genotype–phenotype map for EIF2B2 VWM alleles incomplete","Whether eIF2Bβ has ligand-binding or metabolic-sensing capacity analogous to eIF2Bα is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,3,4,6,15,20,21]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[11]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[11]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[3,8,12,18,19]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,27,22]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[15]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[17,23]}],"complexes":["eIF2B decamer (α₂β₂γ₂δ₂ε₂)","eIF2B regulatory subcomplex (α₂β₂δ₂)"],"partners":["EIF2B1","EIF2B3","EIF2B4","EIF2B5","EIF2S1","EIF2S2","EIF2S3","EIF5"],"other_free_text":[]},"mechanistic_narrative":"EIF2B2 encodes the β-subunit of eIF2B, a heterodecameric guanine nucleotide exchange factor (GEF) and GDI displacement factor (GDF) for eIF2 that is essential for translation initiation. Within the decamer (two copies each of α–ε subunits), the β-subunit is part of the regulatory subcomplex (α/β/δ) that binds phosphorylated eIF2α with high affinity to competitively inhibit nucleotide exchange, thereby transducing the integrated stress response, while the catalytic γ/ε subcomplex catalyzes GDP→GTP exchange on eIF2 through direct contacts with eIF2β and eIF2γ [PMID:8887689, PMID:31048491, PMID:31048492]. eIF2B activity is modulated by GSK-3–mediated phosphorylation of eIF2Bε (Ser535/540), reversed by insulin/PI3K signaling and PP2A, and by allosteric stabilization of the decamer through the small molecule ISRIB or metabolic ligands such as sugar phosphates [PMID:9468292, PMID:25875391, PMID:34103529]. Mutations in EIF2B2 cause Vanishing White Matter disease (leukoencephalopathy with vanishing white matter) by destabilizing the decameric assembly and hypersuppressing translation during stress, disrupting GADD34-mediated feedback recovery of phospho-eIF2α [PMID:29632131, PMID:29489452]."},"prefetch_data":{"uniprot":{"accession":"P49770","full_name":"Translation initiation factor eIF2B subunit beta","aliases":["S20I15","S20III15","eIF2B GDP-GTP exchange factor subunit beta"],"length_aa":351,"mass_kda":39.0,"function":"Acts as a component of the translation initiation factor 2B (eIF2B) complex, which catalyzes the exchange of GDP for GTP on eukaryotic initiation factor 2 (eIF2) gamma subunit (PubMed:25858979, PubMed:27023709, PubMed:31048492). Its guanine nucleotide exchange factor activity is repressed when bound to eIF2 complex phosphorylated on the alpha subunit, thereby limiting the amount of methionyl-initiator methionine tRNA available to the ribosome and consequently global translation is repressed (PubMed:25858979, PubMed:31048492)","subcellular_location":"Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/P49770/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/EIF2B2","classification":"Common Essential","n_dependent_lines":1201,"n_total_lines":1208,"dependency_fraction":0.9942052980132451},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"EIF2S3","stoichiometry":10.0},{"gene":"EIF5","stoichiometry":0.2},{"gene":"NUMA1","stoichiometry":0.2},{"gene":"RACK1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/EIF2B2","total_profiled":1310},"omim":[{"mim_id":"620315","title":"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 5; VWM5","url":"https://www.omim.org/entry/620315"},{"mim_id":"620314","title":"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 4; VWM4","url":"https://www.omim.org/entry/620314"},{"mim_id":"620313","title":"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 3; VWM3","url":"https://www.omim.org/entry/620313"},{"mim_id":"620312","title":"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 2; VWM2","url":"https://www.omim.org/entry/620312"},{"mim_id":"618878","title":"LEUKOENCEPHALOPATHY, MOTOR DELAY, SPASTICITY, AND DYSARTHRIA SYNDROME; LEMSPAD","url":"https://www.omim.org/entry/618878"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Focal adhesion sites","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/EIF2B2"},"hgnc":{"alias_symbol":["EIF2B","EIF-2Bbeta","EIF2Bbeta"],"prev_symbol":[]},"alphafold":{"accession":"P49770","domains":[{"cath_id":"1.20.120.420","chopping":"1-144","consensus_level":"medium","plddt":81.2318,"start":1,"end":144},{"cath_id":"3.40.50.10470","chopping":"150-342","consensus_level":"medium","plddt":90.4751,"start":150,"end":342}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49770","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49770-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49770-F1-predicted_aligned_error_v6.png","plddt_mean":86.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=EIF2B2","jax_strain_url":"https://www.jax.org/strain/search?query=EIF2B2"},"sequence":{"accession":"P49770","fasta_url":"https://rest.uniprot.org/uniprotkb/P49770.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49770/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49770"}},"corpus_meta":[{"pmid":"8397507","id":"PMC_8397507","title":"Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B.","date":"1993","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/8397507","citation_count":349,"is_preprint":false},{"pmid":"11704758","id":"PMC_11704758","title":"Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.","date":"2001","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11704758","citation_count":326,"is_preprint":false},{"pmid":"11835386","id":"PMC_11835386","title":"Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.","date":"2002","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11835386","citation_count":291,"is_preprint":false},{"pmid":"11438658","id":"PMC_11438658","title":"Tight binding of the phosphorylated alpha subunit of initiation factor 2 (eIF2alpha) to the regulatory subunits of guanine nucleotide exchange factor eIF2B is required for inhibition of translation initiation.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11438658","citation_count":283,"is_preprint":false},{"pmid":"9468292","id":"PMC_9468292","title":"Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin.","date":"1998","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9468292","citation_count":242,"is_preprint":false},{"pmid":"9472020","id":"PMC_9472020","title":"eIF2 independently binds two distinct eIF2B subcomplexes that catalyze and regulate guanine-nucleotide exchange.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9472020","citation_count":218,"is_preprint":false},{"pmid":"25875391","id":"PMC_25875391","title":"Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/25875391","citation_count":206,"is_preprint":false},{"pmid":"30624206","id":"PMC_30624206","title":"eIF2B activator prevents neurological defects caused by a chronic integrated stress response.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30624206","citation_count":179,"is_preprint":false},{"pmid":"11041858","id":"PMC_11041858","title":"Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11041858","citation_count":152,"is_preprint":false},{"pmid":"33220178","id":"PMC_33220178","title":"ISRIB Blunts the Integrated Stress Response by Allosterically Antagonising the Inhibitory Effect of Phosphorylated eIF2 on eIF2B.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33220178","citation_count":150,"is_preprint":false},{"pmid":"15136673","id":"PMC_15136673","title":"The effect of genotype on the natural history of eIF2B-related leukodystrophies.","date":"2004","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15136673","citation_count":135,"is_preprint":false},{"pmid":"9812990","id":"PMC_9812990","title":"Implication of eIF2B rather than eIF4E in the regulation of global protein synthesis by amino acids in L6 myoblasts.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9812990","citation_count":132,"is_preprint":false},{"pmid":"14566705","id":"PMC_14566705","title":"eIF2B-related disorders: antenatal onset and involvement of multiple organs.","date":"2003","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14566705","citation_count":125,"is_preprint":false},{"pmid":"1512215","id":"PMC_1512215","title":"Phosphorylation of eukaryotic initiation factor (eIF) 2 alpha and inhibition of eIF-2B in GH3 pituitary cells by perturbants of early protein processing that induce GRP78.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1512215","citation_count":116,"is_preprint":false},{"pmid":"16246152","id":"PMC_16246152","title":"eIF2B, a mediator of general and gene-specific translational control.","date":"2005","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/16246152","citation_count":113,"is_preprint":false},{"pmid":"7565788","id":"PMC_7565788","title":"Modulation of tRNA(iMet), eIF-2, and eIF-2B expression shows that GCN4 translation is inversely coupled to the level of eIF-2.GTP.Met-tRNA(iMet) ternary complexes.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7565788","citation_count":112,"is_preprint":false},{"pmid":"31119045","id":"PMC_31119045","title":"The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility.","date":"2019","source":"Cancer biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31119045","citation_count":107,"is_preprint":false},{"pmid":"22231169","id":"PMC_22231169","title":"Toll-like receptor activation suppresses ER stress factor CHOP and translation inhibition through activation of eIF2B.","date":"2012","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22231169","citation_count":107,"is_preprint":false},{"pmid":"16246171","id":"PMC_16246171","title":"The large spectrum of eIF2B-related diseases.","date":"2006","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/16246171","citation_count":99,"is_preprint":false},{"pmid":"29489452","id":"PMC_29489452","title":"The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/29489452","citation_count":99,"is_preprint":false},{"pmid":"31048491","id":"PMC_31048491","title":"eIF2B-catalyzed nucleotide exchange and phosphoregulation by the integrated stress response.","date":"2019","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/31048491","citation_count":95,"is_preprint":false},{"pmid":"19625339","id":"PMC_19625339","title":"Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.","date":"2009","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19625339","citation_count":92,"is_preprint":false},{"pmid":"8626696","id":"PMC_8626696","title":"T-cell activation leads to rapid stimulation of translation initiation factor eIF2B and inactivation of glycogen synthase kinase-3.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626696","citation_count":90,"is_preprint":false},{"pmid":"31048492","id":"PMC_31048492","title":"Structural basis for eIF2B inhibition in integrated stress response.","date":"2019","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/31048492","citation_count":89,"is_preprint":false},{"pmid":"7893825","id":"PMC_7893825","title":"The guanine nucleotide-exchange factor, eIF-2B.","date":"1994","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/7893825","citation_count":89,"is_preprint":false},{"pmid":"12356745","id":"PMC_12356745","title":"Characterization of the minimal catalytic domain within eIF2B: the guanine-nucleotide exchange factor for translation initiation.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12356745","citation_count":89,"is_preprint":false},{"pmid":"9237674","id":"PMC_9237674","title":"Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3-kinase.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9237674","citation_count":86,"is_preprint":false},{"pmid":"9582312","id":"PMC_9582312","title":"Regulation of guanine nucleotide exchange through phosphorylation of eukaryotic initiation factor eIF2alpha. Role of the alpha- and delta-subunits of eiF2b.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9582312","citation_count":85,"is_preprint":false},{"pmid":"10805739","id":"PMC_10805739","title":"Identification of domains and residues within the epsilon subunit of eukaryotic translation initiation factor 2B (eIF2Bepsilon) required for guanine nucleotide exchange reveals a novel activation function promoted by eIF2B complex formation.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10805739","citation_count":84,"is_preprint":false},{"pmid":"29989343","id":"PMC_29989343","title":"Regulation of translation initiation factor eIF2B at the hub of the integrated stress response.","date":"2018","source":"Wiley interdisciplinary reviews. RNA","url":"https://pubmed.ncbi.nlm.nih.gov/29989343","citation_count":79,"is_preprint":false},{"pmid":"9438375","id":"PMC_9438375","title":"Eukaryotic initiation factor 2B (eIF2B).","date":"1997","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9438375","citation_count":77,"is_preprint":false},{"pmid":"17329232","id":"PMC_17329232","title":"eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?","date":"2007","source":"Schizophrenia bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/17329232","citation_count":77,"is_preprint":false},{"pmid":"10827017","id":"PMC_10827017","title":"Endotoxin-induced decrease in muscle protein synthesis is associated with changes in eIF2B, eIF4E, and IGF-I.","date":"2000","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10827017","citation_count":76,"is_preprint":false},{"pmid":"10444422","id":"PMC_10444422","title":"Inhibition of muscle protein synthesis by alcohol is associated with modulation of eIF2B and eIF4E.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10444422","citation_count":75,"is_preprint":false},{"pmid":"8887689","id":"PMC_8887689","title":"Identification of a regulatory subcomplex in the guanine nucleotide exchange factor eIF2B that mediates inhibition by phosphorylated eIF2.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8887689","citation_count":75,"is_preprint":false},{"pmid":"8567668","id":"PMC_8567668","title":"Glucose stimulates the activity of the guanine nucleotide-exchange factor eIF-2B in isolated rat islets of Langerhans.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8567668","citation_count":73,"is_preprint":false},{"pmid":"12556349","id":"PMC_12556349","title":"Reduced amino acid availability inhibits muscle protein synthesis and decreases activity of initiation factor eIF2B.","date":"2003","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12556349","citation_count":72,"is_preprint":false},{"pmid":"16041584","id":"PMC_16041584","title":"Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16041584","citation_count":65,"is_preprint":false},{"pmid":"10776669","id":"PMC_10776669","title":"Impaired protein synthesis induced by acute alcohol intoxication is associated with changes in eIF4E in muscle and eIF2B in liver.","date":"2000","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/10776669","citation_count":65,"is_preprint":false},{"pmid":"11707417","id":"PMC_11707417","title":"A novel eIF2B-dependent mechanism of translational control in yeast as a response to fusel alcohols.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11707417","citation_count":65,"is_preprint":false},{"pmid":"24352424","id":"PMC_24352424","title":"eIF2B promotes eIF5 dissociation from eIF2*GDP to facilitate guanine nucleotide exchange for translation initiation.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/24352424","citation_count":64,"is_preprint":false},{"pmid":"29036434","id":"PMC_29036434","title":"Novel mechanisms of eIF2B action and regulation by eIF2α phosphorylation.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/29036434","citation_count":59,"is_preprint":false},{"pmid":"21560189","id":"PMC_21560189","title":"Severity of vanishing white matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes.","date":"2011","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/21560189","citation_count":59,"is_preprint":false},{"pmid":"24852487","id":"PMC_24852487","title":"eIF2B is a decameric guanine nucleotide exchange factor with a γ2ε2 tetrameric core.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24852487","citation_count":59,"is_preprint":false},{"pmid":"15798194","id":"PMC_15798194","title":"PKR and GCN2 kinases and guanine nucleotide exchange factor eukaryotic translation initiation factor 2B (eIF2B) recognize overlapping surfaces on eIF2alpha.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15798194","citation_count":58,"is_preprint":false},{"pmid":"33688831","id":"PMC_33688831","title":"eIF2B conformation and assembly state regulate the integrated stress response.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33688831","citation_count":57,"is_preprint":false},{"pmid":"7803480","id":"PMC_7803480","title":"Purification and characterization of eukaryotic translational initiation factor eIF-2B from liver.","date":"1994","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/7803480","citation_count":56,"is_preprint":false},{"pmid":"24532666","id":"PMC_24532666","title":"Analysis of the subunit organization of the eIF2B complex reveals new insights into its structure and regulation.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24532666","citation_count":53,"is_preprint":false},{"pmid":"9488678","id":"PMC_9488678","title":"Nerve and epidermal growth factor induce protein synthesis and eIF2B activation in PC12 cells.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9488678","citation_count":53,"is_preprint":false},{"pmid":"26614666","id":"PMC_26614666","title":"eIF2B: recent structural and functional insights into a key regulator of translation.","date":"2015","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/26614666","citation_count":52,"is_preprint":false},{"pmid":"8164676","id":"PMC_8164676","title":"Mutations in the GCD7 subunit of yeast guanine nucleotide exchange factor eIF-2B overcome the inhibitory effects of phosphorylated eIF-2 on translation initiation.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8164676","citation_count":52,"is_preprint":false},{"pmid":"16157703","id":"PMC_16157703","title":"Dynamic cycling of eIF2 through a large eIF2B-containing cytoplasmic body: implications for translation control.","date":"2005","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16157703","citation_count":51,"is_preprint":false},{"pmid":"9341116","id":"PMC_9341116","title":"Inactivation of eIF2B and phosphorylation of PHAS-I in heat-shocked rat hepatoma cells.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9341116","citation_count":48,"is_preprint":false},{"pmid":"8168527","id":"PMC_8168527","title":"Use of monoclonal antibodies to study the structure and function of eukaryotic protein synthesis initiation factor eIF-2B.","date":"1994","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8168527","citation_count":48,"is_preprint":false},{"pmid":"9446619","id":"PMC_9446619","title":"Identification of interprotein interactions between the subunits of eukaryotic initiation factors eIF2 and eIF2B.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9446619","citation_count":44,"is_preprint":false},{"pmid":"28244149","id":"PMC_28244149","title":"Eukaryotic translation initiation factor 2B-beta (eIF2Bβ), a new class of plant virus resistance gene.","date":"2017","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28244149","citation_count":43,"is_preprint":false},{"pmid":"18263758","id":"PMC_18263758","title":"Genetic and clinical heterogeneity in eIF2B-related disorder.","date":"2008","source":"Journal of child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18263758","citation_count":42,"is_preprint":false},{"pmid":"11323413","id":"PMC_11323413","title":"Characterization of the mammalian initiation factor eIF2B complex as a GDP dissociation stimulator protein.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11323413","citation_count":42,"is_preprint":false},{"pmid":"8007958","id":"PMC_8007958","title":"Expression of mutant eukaryotic initiation factor 2 alpha subunit (eIF-2 alpha) reduces inhibition of guanine nucleotide exchange activity of eIF-2B mediated by eIF-2 alpha phosphorylation.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8007958","citation_count":41,"is_preprint":false},{"pmid":"25486352","id":"PMC_25486352","title":"A new function and complexity for protein translation initiation factor eIF2B.","date":"2014","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25486352","citation_count":40,"is_preprint":false},{"pmid":"12133000","id":"PMC_12133000","title":"Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12133000","citation_count":40,"is_preprint":false},{"pmid":"28306143","id":"PMC_28306143","title":"Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease.","date":"2017","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28306143","citation_count":39,"is_preprint":false},{"pmid":"32690955","id":"PMC_32690955","title":"Inhibition of the integrated stress response by viral proteins that block p-eIF2-eIF2B association.","date":"2020","source":"Nature microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32690955","citation_count":38,"is_preprint":false},{"pmid":"29632131","id":"PMC_29632131","title":"EIF2B2 mutations in vanishing white matter disease hypersuppress translation and delay recovery during the integrated stress response.","date":"2018","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29632131","citation_count":37,"is_preprint":false},{"pmid":"11060303","id":"PMC_11060303","title":"Characterization of the initiation factor eIF2B and its regulation in Drosophila melanogaster.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11060303","citation_count":37,"is_preprint":false},{"pmid":"20016818","id":"PMC_20016818","title":"Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20016818","citation_count":37,"is_preprint":false},{"pmid":"15776425","id":"PMC_15776425","title":"Identification of ten novel mutations in patients with eIF2B-related disorders.","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15776425","citation_count":37,"is_preprint":false},{"pmid":"32200625","id":"PMC_32200625","title":"eIF2B and the Integrated Stress Response: A Structural and Mechanistic View.","date":"2020","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32200625","citation_count":35,"is_preprint":false},{"pmid":"2842334","id":"PMC_2842334","title":"Regulation of protein synthesis in rabbit reticulocyte lysate. Glucose 6-phosphate is required to maintain the activity of eukaryotic initiation factor (eIF)-2B by a mechanism that is independent of the phosphorylation of eIF-2 alpha.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2842334","citation_count":33,"is_preprint":false},{"pmid":"29425030","id":"PMC_29425030","title":"eIF2B Mechanisms of Action and Regulation: A Thermodynamic View.","date":"2018","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29425030","citation_count":32,"is_preprint":false},{"pmid":"20444979","id":"PMC_20444979","title":"Fusel alcohols regulate translation initiation by inhibiting eIF2B to reduce ternary complex in a mechanism that may involve altering the integrity and dynamics of the eIF2B body.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20444979","citation_count":32,"is_preprint":false},{"pmid":"12773302","id":"PMC_12773302","title":"Caerulein-induced acute pancreatitis inhibits protein synthesis through effects on eIF2B and eIF4F.","date":"2003","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12773302","citation_count":32,"is_preprint":false},{"pmid":"10852917","id":"PMC_10852917","title":"Purification and kinetic analysis of eIF2B from Saccharomyces cerevisiae.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10852917","citation_count":31,"is_preprint":false},{"pmid":"26384431","id":"PMC_26384431","title":"Architecture of the eIF2B regulatory subcomplex and its implications for the regulation of guanine nucleotide exchange on eIF2.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26384431","citation_count":30,"is_preprint":false},{"pmid":"10593901","id":"PMC_10593901","title":"Leucine, glutamine, and tyrosine reciprocally modulate the translation initiation factors eIF4F and eIF2B in perfused rat liver.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10593901","citation_count":29,"is_preprint":false},{"pmid":"15215245","id":"PMC_15215245","title":"Crystal structure of yeast Ypr118w, a methylthioribose-1-phosphate isomerase related to regulatory eIF2B subunits.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15215245","citation_count":29,"is_preprint":false},{"pmid":"27462419","id":"PMC_27462419","title":"eIF2 interactions with initiator tRNA and eIF2B are regulated by post-translational modifications and conformational dynamics.","date":"2015","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/27462419","citation_count":28,"is_preprint":false},{"pmid":"17526738","id":"PMC_17526738","title":"Critical contacts between the eukaryotic initiation factor 2B (eIF2B) catalytic domain and both eIF2beta and -2gamma mediate guanine nucleotide exchange.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17526738","citation_count":28,"is_preprint":false},{"pmid":"34876589","id":"PMC_34876589","title":"eIF2B-capturing viral protein NSs suppresses the integrated stress response.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34876589","citation_count":27,"is_preprint":false},{"pmid":"16376935","id":"PMC_16376935","title":"Diversification of catalytic activities and ligand interactions in the protein fold shared by the sugar isomerases, eIF2B, DeoR transcription factors, acyl-CoA transferases and methenyltetrahydrofolate synthetase.","date":"2005","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16376935","citation_count":27,"is_preprint":false},{"pmid":"9631509","id":"PMC_9631509","title":"Reconstitution and purification of eukaryotic initiation factor 2B (eIF2B) expressed in Sf21 insect cells.","date":"1998","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/9631509","citation_count":26,"is_preprint":false},{"pmid":"21795329","id":"PMC_21795329","title":"The alpha subunit of eukaryotic initiation factor 2B (eIF2B) is required for eIF2-mediated translational suppression of vesicular stomatitis virus.","date":"2011","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/21795329","citation_count":25,"is_preprint":false},{"pmid":"6088496","id":"PMC_6088496","title":"The association of eIF-2 with Met-tRNAi or eIF-2B alters the specificity of eIF-2 phosphatase.","date":"1984","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6088496","citation_count":25,"is_preprint":false},{"pmid":"19616556","id":"PMC_19616556","title":"Archaeal aIF2B interacts with eukaryotic translation initiation factors eIF2alpha and eIF2Balpha: Implications for aIF2B function and eIF2B regulation.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19616556","citation_count":24,"is_preprint":false},{"pmid":"11804848","id":"PMC_11804848","title":"Effect of CCK and intracellular calcium to regulate eIF2B and protein synthesis in rat pancreatic acinar cells.","date":"2002","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11804848","citation_count":24,"is_preprint":false},{"pmid":"8929216","id":"PMC_8929216","title":"eIF2B, the guanine nucleotide-exchange factor for eukaryotic initiation factor 2. Sequence conservation between the alpha, beta and delta subunits of eIF2B from mammals and yeast.","date":"1996","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/8929216","citation_count":24,"is_preprint":false},{"pmid":"10563826","id":"PMC_10563826","title":"Serine 48 in initiation factor 2 alpha (eIF2 alpha) is required for high-affinity interaction between eIF2 alpha(P) and eIF2B.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10563826","citation_count":23,"is_preprint":false},{"pmid":"23056417","id":"PMC_23056417","title":"Poor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter disease.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23056417","citation_count":23,"is_preprint":false},{"pmid":"32665273","id":"PMC_32665273","title":"eIF2B as a Target for Viral Evasion of PKR-Mediated Translation Inhibition.","date":"2020","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/32665273","citation_count":23,"is_preprint":false},{"pmid":"14565967","id":"PMC_14565967","title":"Alterations in the expression of mRNAs and proteins that code for species relevant to eIF2B activity after an acute bout of resistance exercise.","date":"2003","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/14565967","citation_count":22,"is_preprint":false},{"pmid":"18631136","id":"PMC_18631136","title":"Clues to the mechanism of action of eIF2B, the guanine-nucleotide-exchange factor for translation initiation.","date":"2008","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/18631136","citation_count":21,"is_preprint":false},{"pmid":"27627185","id":"PMC_27627185","title":"Crystal structure of eIF2B and insights into eIF2-eIF2B interactions.","date":"2016","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/27627185","citation_count":20,"is_preprint":false},{"pmid":"34103529","id":"PMC_34103529","title":"Sugar phosphate activation of the stress sensor eIF2B.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34103529","citation_count":20,"is_preprint":false},{"pmid":"19158808","id":"PMC_19158808","title":"Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease.","date":"2009","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19158808","citation_count":20,"is_preprint":false},{"pmid":"10913625","id":"PMC_10913625","title":"The activation of eukaryotic initiation factor (eIF)2B by growth factors in PC12 cells requires MEK/ERK signalling.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10913625","citation_count":20,"is_preprint":false},{"pmid":"32554487","id":"PMC_32554487","title":"Filament formation by the translation factor eIF2B regulates protein synthesis in starved cells.","date":"2020","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/32554487","citation_count":19,"is_preprint":false},{"pmid":"22737209","id":"PMC_22737209","title":"Developmental splicing deregulation in leukodystrophies related to EIF2B mutations.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22737209","citation_count":18,"is_preprint":false},{"pmid":"21486137","id":"PMC_21486137","title":"Epstein-Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: massive mimicry of multiple sclerosis relevant proteins by the Synechococcus phage.","date":"2011","source":"Immunopharmacology and immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/21486137","citation_count":18,"is_preprint":false},{"pmid":"31438897","id":"PMC_31438897","title":"Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia.","date":"2019","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31438897","citation_count":17,"is_preprint":false},{"pmid":"30826455","id":"PMC_30826455","title":"RGS2 promotes the translation of stress-associated proteins ATF4 and CHOP via its eIF2B-inhibitory domain.","date":"2019","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/30826455","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49086,"output_tokens":8185,"usd":0.135017},"stage2":{"model":"claude-opus-4-6","input_tokens":12382,"output_tokens":4899,"usd":0.276577},"total_usd":0.411594,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"GSK-3 phosphorylates the epsilon subunit of eIF2B, and insulin rapidly inactivates GSK-3 (via phosphorylation of GSK-3), leading to reduced phosphorylation and activation of eIF2B; the effect is reversed by protein phosphatase-2A.\",\n      \"method\": \"Kinase assays on Mono-S fractions, immunoblotting with GSK-3α/β isoform-specific antibodies, phosphatase treatment, CHO cells expressing human insulin receptor\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal biochemical evidence (kinase activity, immunoblot, PP2A reversal) with functional link; replicated in multiple subsequent studies\",\n      \"pmids\": [\"8397507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GSK-3 phosphorylates Ser540 (Ser535 in some numbering) of the eIF2Bε subunit, and this phosphorylation inhibits eIF2B nucleotide exchange activity; insulin causes dephosphorylation of this site in a PI3K-dependent manner.\",\n      \"method\": \"Site-directed mutagenesis to identify phosphorylation site, in vitro kinase assay showing GSK-3 inhibits eIF2B activity, phosphorylation state measured in intact cells with PI3K inhibitors\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro assay with site identification (mutagenesis) and in-cell confirmation; replicated across multiple labs\",\n      \"pmids\": [\"9468292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The GCN3 (α), GCD7 (β), and GCD2 (δ) subunits of yeast eIF2B form a stable regulatory subcomplex that mediates inhibition of eIF2B by phosphorylated eIF2α; this subcomplex lacks nucleotide exchange activity.\",\n      \"method\": \"Coimmunoprecipitation of overexpressed subunits, in vivo genetic suppressor analysis, eIF2B activity assays in subunit deletion strains\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus genetic epistasis plus enzymatic activity measurements; foundational study replicated by subsequent biochemistry\",\n      \"pmids\": [\"8887689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Yeast eIF2B comprises two functional subcomplexes: a regulatory subcomplex (GCN3/GCD7/GCD2) that binds eIF2 with higher affinity for phosphorylated eIF2 but lacks exchange activity, and a catalytic subcomplex (GCD1/GCD6) that catalyzes GDP-GTP exchange and is not inhibited by phospho-eIF2.\",\n      \"method\": \"In vitro nucleotide-exchange assay with purified yeast eIF2B and eIF2; affinity-binding assay; characterization of regulatory mutations in GCN3 and GCD7\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro exchange assay with purified components, replicated and extended by subsequent structural studies\",\n      \"pmids\": [\"9472020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Phosphorylated eIF2α (Ser51-P) binds tightly to the eIF2B regulatory subcomplex (containing GCD7/β and GCD2/δ subunits) in vitro, and this tight binding is required for inhibition of eIF2B guanine nucleotide exchange activity; mutations in eIF2α Ser51 or in GCD7 that block inhibition also abolish this interaction.\",\n      \"method\": \"GST pulldown of recombinant eIF2α (phosphorylated and unphosphorylated) with eIF2B regulatory subcomplex; genetic suppressor analysis; in vitro stimulation of binding by Ser51 phosphorylation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro binding assay with phospho-specific stimulation, corroborated by genetic epistasis; replicated in structural studies\",\n      \"pmids\": [\"11438658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Phosphorylation of eIF2α Ser51 promotes complex formation between phospho-eIF2α and eIF2B, inhibiting eIF2B guanine nucleotide exchange activity; the Ser51Asp (phosphomimetic) mutant but not Ser51Ala mimics this inhibition.\",\n      \"method\": \"Baculovirus expression of wild-type, S51A, and S51D eIF2α mutants; in vitro GNE assay in reticulocyte lysate; interaction measured by co-precipitation\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis; consistent with multiple independent labs\",\n      \"pmids\": [\"11041858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The α- and δ-subunits of mammalian eIF2B mediate sensitivity to inhibition by phosphorylated eIF2; eIF2B lacking the α-subunit is insensitive to eIF2(αP) and can exchange guanine nucleotides using eIF2(αP) as substrate; a double point mutation in the δ-subunit also confers insensitivity.\",\n      \"method\": \"Baculovirus co-expression of all five rat eIF2B subunits; purification of holoprotein and four-subunit complex; in vitro GNE assay with phosphorylated and unphosphorylated eIF2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with purified recombinant complex and mutagenesis; first direct biochemical evidence for α/δ subunit roles\",\n      \"pmids\": [\"9582312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"eIF2 interacts with eIF2B specifically through the δ- and ε-subunits of eIF2B, and the binding site on eIF2β for eIF2B subunits maps to approximately 70 amino acids at the C-terminus; phosphorylation of eIF2α does not promote binding of eIF2B to isolated eIF2α but increases overall affinity of eIF2B for the eIF2 heterotrimer.\",\n      \"method\": \"Far-Western blot analysis mapping eIF2-eIF2B inter-subunit contacts; binding experiments with phosphorylated eIF2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab far-Western method; consistent with but partially superseded by structural data\",\n      \"pmids\": [\"9446619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The C-terminal region of the yeast eIF2Bε subunit (residues 518–712) constitutes the catalytic domain sufficient for nucleotide exchange activity and eIF2 binding; the N-terminal half of eIF2Bε is an activation domain that responds to complex formation with other eIF2B subunits to enhance exchange rate.\",\n      \"method\": \"N-terminal and C-terminal deletion analysis of yeast GCD6 (eIF2Bε) in vitro and in vivo; yeast complementation assays; GEF activity assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro and in vivo functional dissection with defined deletion series; replicated by Gomez et al. 2002\",\n      \"pmids\": [\"10805739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The smallest catalytically active fragment of eIF2Bε (yeast Gcd6p residues 518–712) is sufficient for nucleotide exchange; deletion to residue 581 retains eIF2 binding but abolishes exchange, separating binding from catalytic function.\",\n      \"method\": \"In vitro GEF activity assays with N-terminal deletion series; eIF2-binding assays; in vivo complementation\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with defined deletion constructs and functional validation\",\n      \"pmids\": [\"12356745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mammalian eIF2B acts as a GDP dissociation stimulator (GDS) protein, releasing eIF2-bound GDP even without free nucleotide; the β-subunit of eIF2B, not the ε-subunit, interacts with GTP; the α-subunit is required for full exchange activity of the mammalian holoenzyme.\",\n      \"method\": \"In vitro GDP dissociation assay with purified mammalian eIF2B; GTP-binding assay of individual subunits; reconstitution of activity by adding recombinant eIF2Bα to α-deficient preparations\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified components; multiple assays including GTP-binding and GDP-release\",\n      \"pmids\": [\"11323413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"eIF2B and eIF2 co-localize to a specific large cytoplasmic body in yeast; eIF2 dynamically shuttles into these foci (FRAP analysis), while eIF2B is largely resident; three independent strategies to reduce eIF2B GEF activity all inhibit eIF2 shuttling, implicating this body as the site of guanine nucleotide exchange.\",\n      \"method\": \"Fluorescence microscopy co-localization; FRAP; genetic and pharmacological inhibition of eIF2B activity combined with localization readout\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct live-cell imaging (FRAP) tied to functional consequence; multiple orthogonal approaches in one study\",\n      \"pmids\": [\"16157703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The eIF2B conserved residue E569 in the eIF2Bε catalytic domain is universally essential for GEF activity; W699 on a separate surface (~40 Å away) is critical for interaction with eIF2β; residues L568/E569 and W699 both contact eIF2γ, establishing that multiple surfaces of eIF2Bε mediate nucleotide exchange through contacts with both eIF2β and eIF2γ.\",\n      \"method\": \"Alanine-scanning mutagenesis of conserved surface residues; yeast complementation; in vitro GEF activity assay; binding assays with eIF2 subunits\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro assay plus mutagenesis plus in vivo validation; mechanistically precise\",\n      \"pmids\": [\"17526738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"eIF2B is a decamer (dimer of pentamers) rather than a pentamer, assembled through catalytic γ- and ε-subunits as a core with regulatory subunits arranged in asymmetric trimers; GTP binds to eIF2Bγ; cross-linking places eIF2 contacts at interfaces relevant to nucleotide exchange and its control.\",\n      \"method\": \"Native mass spectrometry, chemical cross-linking, surface accessibility measurements, homology modelling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal MS-based structural methods; confirmed by subsequent cryo-EM studies\",\n      \"pmids\": [\"24852487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Mammalian eIF2B is a decamer (dimer of eIF2BβγδεΑ pentamers), stabilized by two copies of eIF2Bα; eIF2Bδ plays a pivotal role in formation of the eIF2B(βγδε) tetramer; decameric eIF2B shows greater eIF2-binding activity than tetramers, explaining higher activity of the holoenzyme.\",\n      \"method\": \"Native mass spectrometry, co-immunoprecipitation of overexpressed complexes, eIF2-binding assays, analysis of eIF2B subunit levels across mouse tissues\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — native MS plus reciprocal Co-IP plus functional binding assays; consistent with Gordiyenko et al. 2014\",\n      \"pmids\": [\"24532666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"eIF2B has a GDI displacement factor (GDF) activity: the eIF2Bγ and eIF2Bε subunits displace eIF5 (which acts as a GDI for eIF2·GDP) from the eIF2·GDP/eIF5 complex prior to GEF action; GDF activity is insensitive to eIF2α phosphorylation (unlike GEF), and eIF2Bγ mutations impairing GCN4 control selectively impair GDF but not GEF function.\",\n      \"method\": \"Protein-protein interaction assays; nucleotide exchange kinetics; genetic analysis of eIF2Bγ mutations; separation of GDF and GEF activities\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — kinetic assays plus mutagenesis distinguishing GDF from GEF; novel functional dissection in one study with orthogonal methods\",\n      \"pmids\": [\"24352424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ISRIB (a small molecule) activates eIF2B by stabilizing eIF2B dimers (decamers); ISRIB activity requires eIF2B (shown by shRNA screen); the eIF2B4 (δ-subunit) contributes to the ISRIB binding site; ISRIB renders cells insensitive to eIF2α phosphorylation by activating eIF2B.\",\n      \"method\": \"Reporter-based shRNA screen; biochemical stabilization of eIF2B dimers; structural analysis; cell-based ISR assay; development of analog series\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional genetic screen plus biochemical stabilization; replicated and extended by subsequent structural studies\",\n      \"pmids\": [\"25875391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"VWM disease mutations in eIF2B destabilize the decameric eIF2B holoenzyme; ISRIB rescues stability of VWMD mutant eIF2B by stabilizing the decameric form and restores residual catalytic activity to wild-type levels; ISRIB blocks ISR activation in VWMD patient cells.\",\n      \"method\": \"Biochemical stability assays of mutant eIF2B complexes; GEF activity assays; cell-based ISR reporter assays; SEC/MS analysis of complex assembly\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro biochemical assays plus mutagenesis plus cell-based functional assay; multiple orthogonal methods\",\n      \"pmids\": [\"29489452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Cryo-EM structures of eIF2 bound to eIF2B reveal that the eIF2B heterodecamer is a static platform; one or two flexible eIF2 trimers bind and align with eIF2B's bipartite catalytic centers to catalyze nucleotide exchange; phosphorylation refolds eIF2α to contact eIF2B at a different interface, sequestering it in a nonproductive complex.\",\n      \"method\": \"Cryo-electron microscopy structural determination\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structure with mechanistic interpretation; confirmed by independent concurrent study (Kashiwagi et al. 2019)\",\n      \"pmids\": [\"31048491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Cryo-EM and crystal structures of eIF2B in complex with unphosphorylated or phosphorylated eIF2 show that the two forms bind eIF2B in completely different modes: unphosphorylated eIF2 in a nucleotide exchange-active mode, phosphorylated eIF2 in an exchange-inactive mode that dominantly inhibits eIF2B.\",\n      \"method\": \"Cryo-electron microscopy and X-ray crystallography of eIF2B·eIF2 complexes\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — atomic-resolution structural determination with two distinct substrate states; independent replication of the Kenner et al. 2019 structures\",\n      \"pmids\": [\"31048492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ISRIB antagonizes the ISR by allosteric mechanism: ISRIB-mediated acceleration of eIF2B nucleotide exchange is observed preferentially in the presence of phospho-eIF2; eIF2(αP) engagement of both eIF2B regulatory sites remodels the ISRIB-binding pocket and exchange-active pockets; eIF2(αP) and ISRIB reciprocally oppose each other's binding to eIF2B.\",\n      \"method\": \"Cryo-EM of eIF2B with eIF2(αP) and ISRIB; in vitro nucleotide exchange assay; eIF2B binding studies with ISR inhibitor and inhibitor-resistant mutants\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM plus in vitro reconstitution plus mutagenesis; mechanistically precise antagonistic allostery model\",\n      \"pmids\": [\"33220178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"eIF2B assembly state regulates ISR: in the absence of eIF2Bα, unassembled eIF2B tetramer subcomplexes accumulate and induce ISR; ISRIB drives assembly of inactive tetramers into active octamers/decamers; cryo-EM reveals eIF2(αP) converts eIF2B decamers into 'conjoined tetramers' with diminished substrate binding and catalytic activity via a conformational rocking motion.\",\n      \"method\": \"Cryo-EM; in vitro assembly/disassembly monitoring; in vivo ISRIB treatment; eIF2Bα knockout cell lines\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM plus in vivo genetic manipulation plus biochemical assembly assays; multiple orthogonal approaches\",\n      \"pmids\": [\"33688831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TLR-TRIF signaling activates eIF2B GEF activity through PP2A-mediated serine dephosphorylation of the eIF2Bε subunit; PP2A is itself activated by decreased Src-family-kinase-induced tyrosine phosphorylation of its catalytic subunit; this pathway suppresses CHOP induction and translational repression in ER-stressed cells.\",\n      \"method\": \"PP2A activity assay; phosphorylation state analysis of eIF2Bε; siRNA knockdown of pathway components; in vivo mouse model of ER stress with TLR activation\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (kinase assays, phospho-state, KD, in vivo) in single high-impact study\",\n      \"pmids\": [\"22231169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"EIF2B2 mutations in VWMD patient cells hypersuppress translation during the ISR (ER stress), delaying stress-induced gene expression and interrupting GADD34-mediated negative feedback dephosphorylation of phospho-eIF2α, causing prolonged translational hyperrepression and failure to recover from stress.\",\n      \"method\": \"Translation rate measurements in patient fibroblasts; ISR reporter assays; GADD34 feedback analysis; small-molecule rescue (ISRIB and PERK inhibitor) in patient cells\",\n      \"journal\": \"RNA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — patient-derived cells, multiple assays, pharmacological rescue; mechanistically defines EIF2B2 mutation effect on ISR dynamics\",\n      \"pmids\": [\"29632131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Sugar phosphates (e.g., glucose-6-phosphate) occupy an ancestral catalytic site in the eIF2Bα subunit, promote eIF2B holoenzyme formation, and enhance eIF2B GEF activity; a VWM disease mutation in the eIF2Bα ligand-binding pocket fails to engage sugar phosphates and is not stimulated by them.\",\n      \"method\": \"Unbiased ligand binding screens; enzymatic activity assays; structural studies of eIF2Bα with sugar phosphate ligands; analysis of VWM mutant\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — binding screens plus structural studies plus functional assay plus disease-relevant mutagenesis\",\n      \"pmids\": [\"34103529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SFSV nonstructural protein NSs binds to the α-subunit of eIF2B in a manner competitive with phospho-eIF2α, allowing eIF2B to retain nucleotide exchange activity even in the presence of phospho-eIF2; cryo-EM of eIF2B·NSs·unphosphorylated eIF2 complex reveals the structural basis for ISR suppression.\",\n      \"method\": \"Cryo-EM structural determination; in vitro GEF activity assay in presence of NSs and eIF2(αP); ribosome profiling in NSs-expressing cells\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure plus in vitro functional assay plus genome-wide ribosome profiling\",\n      \"pmids\": [\"34876589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Viral proteins (from a coronavirus and a picornavirus) independently acquired the ability to act as competitive inhibitors of phospho-eIF2–eIF2B interaction, allowing continued eIF2B-mediated GTP exchange and global translation despite high phospho-eIF2 levels.\",\n      \"method\": \"Cell-based ISR reporter assays; competition binding experiments; translation assays in virus-infected cells\",\n      \"journal\": \"Nature microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assay with mechanistic placement; single study\",\n      \"pmids\": [\"32690955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Insulin activates eIF2B through a signaling pathway requiring PI3K; activation is blocked by dominant-negative PI3K and PI3K inhibitors but not rapamycin or a Sos mutant; eIF2B and GSK-3 are regulated reciprocally, and dominant-negative PI3K abolishes insulin-induced GSK-3 inhibition, placing PI3K upstream of GSK-3 in the eIF2B activation pathway.\",\n      \"method\": \"PI3K inhibitors (wortmannin), dominant-negative PI3K/Sos mutants, GSK-3 and eIF2B activity assays, rapamycin treatment\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with dominant-negative constructs and pharmacological inhibitors; replicated across multiple studies\",\n      \"pmids\": [\"9237674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In S. cerevisiae, a proline-to-serine allelic variant at position 180 of the GCD1 (eIF2Bγ) subunit confers translational regulation in response to fusel alcohols; fusel alcohols target eIF2B to inhibit translation initiation.\",\n      \"method\": \"Genetic mapping; strain-specific phenotypic analysis; translation assays in eIF2B subunit mutants\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic mapping to specific eIF2Bγ residue with functional translation assay; single lab\",\n      \"pmids\": [\"11707417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Under starvation-induced cytosolic acidification, yeast eIF2B forms enzymatically inactive filaments that promote rapid and efficient downregulation of translation; filamentation is independent of the Gcn2 kinase pathway and site-specific variants suggest assembly leads to inactive filaments supporting stress survival and fast recovery.\",\n      \"method\": \"Fluorescence microscopy of eIF2B filaments; pH measurements; site-directed mutagenesis; translation assays in filament-incompetent mutants; stress survival assays\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct imaging plus functional mutagenesis; novel mechanism but single lab, yeast model\",\n      \"pmids\": [\"32554487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structure of the eIF2B regulatory subcomplex (RSC) reveals it exists as a hexamer composed of two eIF2Bβδ heterodimers and one eIF2Bα2 homodimer; eIF2Bα specifically binds AMP and GMP as ligands in a pocket homologous to sugar-metabolizing enzymes; structural and mutational data define how RSC interacts with eIF2 and mediates inhibition.\",\n      \"method\": \"X-ray crystallography of eIF2Bβ, eIF2Bδ, and eIF2B(βδ)2 from Chaetomium thermophilum; solution biochemistry showing hexameric assembly; mutational analysis; ligand binding assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures of multiple RSC components plus biochemical and mutational validation\",\n      \"pmids\": [\"26384431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure of Schizosaccharomyces pombe eIF2B decamer reveals the structural mechanism by which phosphorylation of eIF2α Ser51 inhibits eIF2B GEF activity; structure-based in vitro analyses confirm mechanism.\",\n      \"method\": \"X-ray crystallography of full eIF2B decamer; structure-based in vitro GEF activity analyses\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — first crystal structure of full eIF2B decamer with structure-based functional validation\",\n      \"pmids\": [\"27627185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"eIF2α phosphorylation destabilizes an autoregulatory intramolecular interaction within eIF2α (novel inhibition mechanism); NMR and fluorescence spectroscopy provide the first structural model of the eIF2B·eIF2-GDP complex and intermediates including apo-eIF2 and eIF2-GTP, directly informing the catalytic mechanism.\",\n      \"method\": \"NMR spectroscopy; fluorescence spectroscopy; site-directed mutagenesis; thermodynamic analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR plus fluorescence plus mutagenesis plus thermodynamics; multiple orthogonal methods in one study\",\n      \"pmids\": [\"29036434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RGS2, via its eIF2B-interacting domain, interacts with eIF2B and inhibits global protein synthesis; this interaction selectively promotes translational upregulation of ATF4 and CHOP in a manner independent of eIF2α phosphorylation.\",\n      \"method\": \"Expression of full-length RGS2 and its eIF2B-binding domain fragment; translation rate assays; ATF4/CHOP protein level measurements; cell-based ISR assays\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, overexpression approach with functional protein-level readout; mechanistic placement proposed but not fully reconstituted\",\n      \"pmids\": [\"30826455\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"eIF2B is a heterodecameric (dimer of pentamers, subunits α–ε × 2) guanine nucleotide exchange factor (GEF) and GDI displacement factor (GDF) for eIF2, where the catalytic γ/ε subcomplex catalyzes GDP→GTP exchange via direct contacts with both eIF2β and eIF2γ, the regulatory α/β/δ subcomplex binds phospho-eIF2α with high affinity to competitively inhibit exchange (integrated stress response), GSK-3 phosphorylates eIF2Bε at Ser535/540 to inhibit activity while insulin/PI3K signaling inactivates GSK-3 to dephosphorylate and activate eIF2B, ISRIB activates eIF2B by allosterically stabilizing the decameric assembly and antagonizing the conformational changes induced by phospho-eIF2α, and EIF2B2 (β-subunit) mutations cause Vanishing White Matter disease by destabilizing the decamer and hypersuppressing translation during stress.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"EIF2B2 encodes the β-subunit of eIF2B, a heterodecameric guanine nucleotide exchange factor (GEF) and GDI displacement factor (GDF) for eIF2 that is essential for translation initiation. Within the decamer (two copies each of α–ε subunits), the β-subunit is part of the regulatory subcomplex (α/β/δ) that binds phosphorylated eIF2α with high affinity to competitively inhibit nucleotide exchange, thereby transducing the integrated stress response, while the catalytic γ/ε subcomplex catalyzes GDP→GTP exchange on eIF2 through direct contacts with eIF2β and eIF2γ [PMID:8887689, PMID:31048491, PMID:31048492]. eIF2B activity is modulated by GSK-3–mediated phosphorylation of eIF2Bε (Ser535/540), reversed by insulin/PI3K signaling and PP2A, and by allosteric stabilization of the decamer through the small molecule ISRIB or metabolic ligands such as sugar phosphates [PMID:9468292, PMID:25875391, PMID:34103529]. Mutations in EIF2B2 cause Vanishing White Matter disease (leukoencephalopathy with vanishing white matter) by destabilizing the decameric assembly and hypersuppressing translation during stress, disrupting GADD34-mediated feedback recovery of phospho-eIF2α [PMID:29632131, PMID:29489452].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing that eIF2B is regulated by insulin-responsive phosphorylation resolved how growth-factor signaling controls translation initiation: GSK-3 directly phosphorylates the eIF2Bε subunit to inhibit GEF activity, and insulin reverses this via GSK-3 inactivation.\",\n      \"evidence\": \"Kinase assays on Mono-S fractions, GSK-3 isoform-specific immunoblots, PP2A reversal in CHO cells expressing human insulin receptor\",\n      \"pmids\": [\"8397507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact phosphorylation site on eIF2Bε not yet mapped\", \"Pathway between insulin receptor and GSK-3 undefined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Defining PI3K as the intermediate between insulin signaling and GSK-3/eIF2B placed eIF2B activation within the canonical PI3K-Akt pathway, establishing eIF2B as a downstream translational effector of growth factor signaling.\",\n      \"evidence\": \"Dominant-negative PI3K, wortmannin, rapamycin insensitivity; GSK-3 and eIF2B activity assays\",\n      \"pmids\": [\"9237674\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Akt directly phosphorylates GSK-3 to control eIF2B not formally shown here\", \"Tissue-specific regulation not addressed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identifying the eIF2B regulatory (α/β/δ) and catalytic (γ/ε) subcomplexes, and showing that the regulatory subcomplex mediates phospho-eIF2α sensitivity while lacking exchange activity, defined the bipartite architecture of eIF2B and the mechanistic basis for ISR transduction.\",\n      \"evidence\": \"Purified yeast and mammalian subcomplexes; in vitro GEF assays with phospho- and unphospho-eIF2; baculovirus reconstitution; mutagenesis of α and δ subunits\",\n      \"pmids\": [\"9472020\", \"9582312\", \"8887689\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the holoenzyme unknown\", \"How phospho-eIF2α binding to regulatory subcomplex inhibits catalytic subcomplex activity unclear\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Mapping the GSK-3 phosphorylation site to Ser540 (Ser535) on eIF2Bε and demonstrating that this single phosphorylation inhibits GEF activity provided the molecular target for PI3K-dependent translational control.\",\n      \"evidence\": \"Site-directed mutagenesis, in vitro kinase assay, phosphorylation-state analysis in intact cells with PI3K inhibitors\",\n      \"pmids\": [\"9468292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional sites contribute to regulation not excluded\", \"Structural basis of inhibition by Ser540 phosphorylation unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrating that a C-terminal fragment of eIF2Bε (residues 518–712) is the minimal catalytic domain sufficient for nucleotide exchange separated catalytic and regulatory functions within a single subunit and showed that complex formation with other subunits enhances activity.\",\n      \"evidence\": \"Deletion analysis of yeast GCD6 in vitro and in vivo; complementation assays; GEF activity assays\",\n      \"pmids\": [\"10805739\", \"12356745\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How N-terminal activation domain of eIF2Bε communicates with catalytic domain structurally undefined\", \"Minimal domain lacks ISR regulation\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showing that phospho-eIF2α binds tightly and specifically to the regulatory subcomplex while mutations abolishing this binding also abolish GEF inhibition established competitive substrate sequestration as the inhibition mechanism.\",\n      \"evidence\": \"GST pulldown with phospho- and unphospho-eIF2α; genetic suppressor analysis in yeast\",\n      \"pmids\": [\"11438658\", \"11041858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural details of the phospho-eIF2α–regulatory subcomplex interface unknown\", \"Whether sequestration is the sole mechanism or allosteric effects contribute unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovering that eIF2B and eIF2 co-localize to a specific cytoplasmic body in yeast where eIF2 dynamically shuttles for nucleotide exchange revealed that GEF activity is spatially organized.\",\n      \"evidence\": \"Fluorescence microscopy co-localization, FRAP, genetic and pharmacological perturbation of eIF2B activity in yeast\",\n      \"pmids\": [\"16157703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian eIF2B forms equivalent bodies not shown\", \"Molecular determinants of body formation unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Alanine-scanning mutagenesis of eIF2Bε showed that the catalytic domain contacts both eIF2β and eIF2γ through spatially separated surfaces (~40 Å apart), establishing that nucleotide exchange requires multipoint engagement of the substrate.\",\n      \"evidence\": \"Conserved-residue mutagenesis, yeast complementation, in vitro GEF and binding assays\",\n      \"pmids\": [\"17526738\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure of the eIF2B–eIF2 interface not yet available\", \"Whether the two contact surfaces function sequentially or simultaneously unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating that TLR-TRIF signaling activates eIF2B through PP2A-mediated dephosphorylation of eIF2Bε revealed an immune-cell-specific input to translational control during ER stress.\",\n      \"evidence\": \"PP2A activity assay, phospho-state analysis of eIF2Bε, siRNA knockdown, in vivo mouse ER stress model with TLR activation\",\n      \"pmids\": [\"22231169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which Src-family kinase member mediates PP2A phosphorylation in this context not identified\", \"Generalizability beyond macrophage/innate immunity not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identifying eIF2B's GDI displacement factor (GDF) activity — mechanistically separable from GEF activity — showed that eIF2Bγ/ε first displace eIF5 (the GDI) from eIF2·GDP before catalyzing exchange, and that ISR phospho-eIF2α selectively inhibits GEF but not GDF.\",\n      \"evidence\": \"Protein interaction and kinetic assays distinguishing GDF from GEF; eIF2Bγ mutations selectively impairing GDF\",\n      \"pmids\": [\"24352424\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of GDF activity unknown\", \"Whether GDF is rate-limiting in vivo not established\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Native mass spectrometry established that eIF2B is a heterodecamer (dimer of pentamers) rather than a pentamer, with eIF2Bα stabilizing the dimer and eIF2Bδ pivotal for tetramer formation, explaining why the holoenzyme has greater substrate-binding and catalytic activity than subcomplexes.\",\n      \"evidence\": \"Native MS, chemical cross-linking, co-IP, eIF2-binding assays, tissue-level subunit stoichiometry\",\n      \"pmids\": [\"24852487\", \"24532666\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure not yet available\", \"How dimerization enhances catalysis mechanistically unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"The discovery that ISRIB activates eIF2B by stabilizing its decameric assembly and rendering cells insensitive to eIF2α phosphorylation provided both a pharmacological tool and a therapeutic lead for ISR-related diseases.\",\n      \"evidence\": \"shRNA screen identifying eIF2B as ISRIB target; biochemical stabilization of eIF2B dimers; eIF2B4 (δ) as binding site component; cell-based ISR assay\",\n      \"pmids\": [\"25875391\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic details of ISRIB binding site on eIF2B not resolved\", \"In vivo pharmacokinetics and CNS penetrance not addressed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystal structures of the eIF2B regulatory subcomplex revealed the hexameric (α₂β₂δ₂) architecture and showed that eIF2Bα binds nucleotide ligands (AMP/GMP) in an ancestral sugar-phosphatase pocket, linking metabolic sensing to translational control.\",\n      \"evidence\": \"X-ray crystallography of eIF2Bβ, δ, and (βδ)₂ from Chaetomium thermophilum; ligand binding assays; mutational analysis\",\n      \"pmids\": [\"26384431\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological significance of nucleotide binding to eIF2Bα unclear\", \"Whether AMP/GMP binding modulates ISR sensitivity untested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The first crystal structure of a full eIF2B decamer (S. pombe) provided the structural framework for understanding how phospho-eIF2α Ser51 inhibits GEF activity at the holoenzyme level.\",\n      \"evidence\": \"X-ray crystallography of full decamer; structure-based in vitro GEF analyses\",\n      \"pmids\": [\"27627185\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of eIF2B bound to eIF2 substrate not available\", \"Mammalian eIF2B structure not yet determined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating that EIF2B2 mutations in VWM patient cells cause hypersuppression of translation during ER stress — by disrupting GADD34-mediated feedback dephosphorylation of phospho-eIF2α — defined the pathogenic mechanism of Vanishing White Matter disease at the translational level.\",\n      \"evidence\": \"Translation rate measurements in patient fibroblasts; ISR reporters; GADD34 feedback analysis; pharmacological rescue with ISRIB and PERK inhibitor\",\n      \"pmids\": [\"29632131\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why white matter is selectively vulnerable not explained\", \"Whether all VWM-causing EIF2B2 alleles act through the same mechanism not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showing that VWM disease mutations destabilize the eIF2B decamer and that ISRIB rescues both stability and catalytic activity connected the biophysical defect (decamer instability) to pathology and validated a therapeutic strategy.\",\n      \"evidence\": \"Biochemical stability assays, GEF activity assays, SEC/MS of mutant complexes, cell-based ISR rescue in VWMD patient cells\",\n      \"pmids\": [\"29489452\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo efficacy of ISRIB in VWM animal models not shown\", \"Not all VWM mutations tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Cryo-EM structures of eIF2B bound to unphosphorylated and phosphorylated eIF2 revealed two completely distinct binding modes — productive (exchange-competent) versus nonproductive (inhibitory) — providing the atomic-level mechanism for ISR-mediated translational control.\",\n      \"evidence\": \"Cryo-EM and X-ray crystallography of eIF2B·eIF2 complexes in both phosphorylation states, from two independent groups\",\n      \"pmids\": [\"31048491\", \"31048492\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transition dynamics between productive and nonproductive modes not captured\", \"Role of individual regulatory subunits including β in the conformational switch not fully dissected\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Structural and biochemical demonstration that ISRIB and phospho-eIF2α reciprocally oppose each other's binding to eIF2B through allosteric remodeling of shared pockets established ISRIB's mechanism as direct antagonism of the ISR conformational switch.\",\n      \"evidence\": \"Cryo-EM of eIF2B with eIF2(αP) and ISRIB; in vitro nucleotide exchange assay; ISRIB-resistant mutants\",\n      \"pmids\": [\"33220178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ISRIB efficacy varies across eIF2B mutant backgrounds (e.g., different VWM alleles) not systematically explored\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Discovery that viral proteins from diverse virus families independently evolved to competitively block phospho-eIF2 binding to eIF2B demonstrated that the regulatory subcomplex interface is a convergent target for immune evasion.\",\n      \"evidence\": \"Cell-based ISR reporter assays; competition binding experiments; translation assays in virus-infected cells\",\n      \"pmids\": [\"32690955\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct structural visualization of viral protein–eIF2B interaction not shown in this study\", \"Breadth across additional virus families not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrating that eIF2(αP) converts active eIF2B decamers into 'conjoined tetramers' with diminished catalysis via a rocking motion, and that ISRIB rescues assembly even without eIF2Bα, unified the assembly-state and allosteric models of ISR regulation.\",\n      \"evidence\": \"Cryo-EM; in vitro assembly monitoring; ISRIB treatment; eIF2Bα knockout cells\",\n      \"pmids\": [\"33688831\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether conjoined tetramers form in vivo under physiological stress not directly demonstrated\", \"Contribution of eIF2Bβ to the rocking conformational change not isolated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of sugar phosphates (e.g., glucose-6-phosphate) as natural ligands that occupy an ancestral catalytic site in eIF2Bα, promote decamer formation, and enhance GEF activity linked cellular metabolic state to eIF2B regulation independently of phospho-eIF2α.\",\n      \"evidence\": \"Unbiased ligand-binding screens; enzymatic activity assays; structural studies; VWM mutant analysis\",\n      \"pmids\": [\"34103529\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological range of sugar-phosphate concentrations needed to modulate eIF2B in vivo not established\", \"Whether eIF2Bβ pocket also binds metabolites not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The specific contribution of the eIF2Bβ subunit to decamer assembly, ISR sensing, and GEF catalysis — as opposed to the roles of the structurally related α and δ subunits — remains incompletely resolved at the atomic level.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No subunit-specific deletion or point-mutation series for EIF2B2 dissecting its unique versus redundant roles within the regulatory subcomplex\", \"Genotype–phenotype map for EIF2B2 VWM alleles incomplete\", \"Whether eIF2Bβ has ligand-binding or metabolic-sensing capacity analogous to eIF2Bα is unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 3, 4, 6, 15, 20, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [3, 8, 12, 18, 19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 27, 22]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [17, 23]}\n    ],\n    \"complexes\": [\n      \"eIF2B decamer (α₂β₂γ₂δ₂ε₂)\",\n      \"eIF2B regulatory subcomplex (α₂β₂δ₂)\"\n    ],\n    \"partners\": [\n      \"EIF2B1\",\n      \"EIF2B3\",\n      \"EIF2B4\",\n      \"EIF2B5\",\n      \"EIF2S1\",\n      \"EIF2S2\",\n      \"EIF2S3\",\n      \"EIF5\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}